Hills Bank & Trust’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $640K | Sell |
3,490
-1,129
| -24% | -$208K | 0.03% | 190 |
|
|
2025
Q4 | $813K | Sell |
4,619
-1,126
| -20% | -$184K | 0.05% | 172 |
|
|
2025
Q3 | $805K | Buy |
5,745
+159
| +3% | +$21.5K | 0.05% | 176 |
|
|
2025
Q2 | $702K | Buy |
5,586
+829
| +17% | +$103K | 0.04% | 179 |
|
|
2025
Q1 | $651K | Buy |
4,757
+187
| +4% | +$26.7K | 0.05% | 170 |
|
|
2024
Q4 | $699K | Buy |
4,570
+207
| +5% | +$34.9K | 0.05% | 161 |
|
|
2024
Q3 | $846K | Buy |
4,363
+13
| +0.3% | +$2.72K | 0.06% | 152 |
|
|
2024
Q2 | $1.01M | Buy |
4,350
+202
| +5% | +$43.9K | 0.08% | 137 |
|
|
2024
Q1 | $894K | Buy |
4,148
+128
| +3% | +$30K | 0.08% | 138 |
|
|
2023
Q4 | $1.04M | Buy |
4,020
+33
| +0.8% | +$8.11K | 0.1% | 123 |
|
|
2023
Q3 | $1.02M | Buy |
3,987
+324
| +9% | +$86.7K | 0.12% | 113 |
|
|
2023
Q2 | $1.04M | Buy |
3,663
+205
| +6% | +$61K | 0.13% | 102 |
|
|
2023
Q1 | $961K | Buy |
3,458
+1,153
| +50% | +$319K | 0.13% | 105 |
|
|
2022
Q4 | $639K | Buy |
2,305
+612
| +36% | +$173K | 0.09% | 122 |
|
|
2022
Q3 | $452K | Buy |
1,693
+1,052
| +164% | +$223K | 0.07% | 138 |
|
|
2022
Q2 | $130K | Buy |
+641
| New | +$131K | 0.02% | 224 |
|
|
2021
Q1 | – | Sell |
-450
| Closed | -$110K | – | 254 |
|
|
2020
Q4 | $110K | Sell |
450
-61
| -12% | -$15.7K | 0.02% | 230 |
|
|
2020
Q3 | $145K | Sell |
511
-909
| -64% | -$254K | 0.03% | 204 |
|
|
2020
Q2 | $380K | Sell |
1,420
-595
| -30% | -$179K | 0.08% | 138 |
|
|
2020
Q1 | $638K | Buy |
2,015
+77
| +4% | +$23.4K | 0.19% | 85 |
|
|
2019
Q4 | $575K | Buy |
1,938
+48
| +3% | +$13.3K | 0.14% | 94 |
|
|
2019
Q3 | $440K | Buy |
1,890
+10
| +0.5% | +$2.33K | 0.11% | 107 |
|
|
2019
Q2 | $439K | Sell |
1,880
-3,117
| -62% | -$720K | 0.11% | 109 |
|
|
2019
Q1 | $1.18M | Buy |
4,997
+66
| +1% | +$20.8K | 0.32% | 71 |
|
|
2018
Q4 | $1.48M | Sell |
4,931
-48
| -1% | -$15.3K | 0.46% | 50 |
|
|
2018
Q3 | $1.76M | Sell |
4,979
-36
| -0.7% | -$12.4K | 0.47% | 49 |
|
|
2018
Q2 | $1.46M | Buy |
5,015
+133
| +3% | +$37.4K | 0.42% | 57 |
|
|
2018
Q1 | $1.34M | Buy |
4,882
+75
| +2% | +$23.3K | 0.4% | 58 |
|
|
2017
Q4 | $1.53M | Sell |
4,807
-17
| -0.4% | -$5.45K | 0.45% | 51 |
|
|
2017
Q3 | $1.51M | Sell |
4,824
-105
| -2% | -$31.1K | 0.47% | 48 |
|
|
2017
Q2 | $1.34M | Buy |
4,929
+222
| +5% | +$58.7K | 0.43% | 53 |
|
|
2017
Q1 | $1.29M | Buy |
4,707
+143
| +3% | +$40.4K | 0.44% | 52 |
|
|
2016
Q4 | $1.29M | Buy |
4,564
+254
| +6% | +$75.3K | 0.45% | 52 |
|
|
2016
Q3 | $1.35M | Buy |
4,310
+945
| +28% | +$280K | 0.49% | 50 |
|
|
2016
Q2 | $813K | Buy |
3,365
+415
| +14% | +$109K | 0.3% | 67 |
|
|
2016
Q1 | $768K | Buy |
2,950
+1,290
| +78% | +$341K | 0.28% | 65 |
|
|
2015
Q4 | $509K | Buy |
+1,660
| New | +$477K | 0.19% | 76 |
|
Other funds holding BIIB
VCM
VPM
Hills Bank & Trust's BIIB Position: Q1 2026 in Review
Hills Bank & Trust reduced its Biogen (BIIB) stake by 24% in Q1 2026, selling an estimated $208K and leaving 3,490 shares worth $640K. The position accounts for 0.03% of the portfolio, ranked #190.
Hills Bank & Trust first reported a position in BIIB in Q4 2015 and has held it in 37 quarters since. The position peaked at $1.76M in Q3 2018. 1,004 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Hills Bank & Trust held 3,490 shares of Biogen worth $640K as of Q1 2026.
- Hills Bank & Trust sold 1,129 Biogen shares in Q1 2026, an estimated $208K.
- Biogen made up 0.03% of Hills Bank & Trust's portfolio in Q1 2026, its #190 holding.
- Hills Bank & Trust first reported a position in Biogen in Q4 2015 and has held it in 37 quarters since.
- Hills Bank & Trust's Biogen position peaked at $1.76M in Q3 2018.
- 1,004 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Hills Bank & Trust's 13F filing for Q1 2026, filed 1 May 2026.